CAOP - Competency Assessment of Overseas Pharmacist Monitoring Medication Outcomes Questions and Answers

Question 1

A 68-year-old male patient on long-term warfarin therapy for atrial fibrillation presents to your pharmacy with a new prescription for amiodarone. His INR has been stable for the past six months, consistently between 2.0 and 3.0. What is the most critical monitoring parameter to assess following the initiation of amiodarone?

Accepted Answer

International Normalised Ratio (INR) within one week.

Answer

Amiodarone is a potent inhibitor of the cytochrome P450 enzymes that metabolise warfarin, leading to a significant drug-drug interaction. This interaction can markedly increase the patient's INR, elevating the risk of bleeding. Therefore, the INR must be monitored closely, typically within a week of starting amiodarone, and the warfarin dose will likely require a significant reduction.

Question 2

Which of the following is a key criterion for a drug to be considered suitable for Therapeutic Drug Monitoring (TDM)?

Accepted Answer

A clear relationship exists between plasma concentration and clinical effect.

Answer

Therapeutic Drug Monitoring (TDM) is most valuable when there is a well-established relationship between the drug's concentration in the plasma and its therapeutic or toxic effects. Drugs with a narrow therapeutic range and significant pharmacokinetic variability are also prime candidates for TDM, as it helps to individualise dosing to ensure efficacy while avoiding toxicity.

Question 3

A pharmacist is conducting a Home Medicines Review (HMR) for an elderly patient who reports increased drowsiness and confusion since starting a new medication for insomnia a month ago. Which of the following is the pharmacist's most important immediate action regarding medication outcomes?

Accepted Answer

Contact the patient's GP to discuss the suspected ADR and recommend a management plan.

Answer

While reporting the ADR to the TGA is important for pharmacovigilance, the pharmacist's primary responsibility is the immediate safety and care of the patient. This involves collaborative practice with the prescriber (the GP) to assess the situation and make a therapeutic decision. The pharmacist should communicate their findings and concerns to the GP to facilitate a timely review and potential adjustment of the patient's therapy. Advising the patient to cease medication unilaterally is outside the pharmacist's scope of practice.

Question 4

When monitoring a patient on gentamicin therapy, a pharmacist notes a higher-than-expected trough level. This finding primarily indicates an increased risk of which of the following adverse effects?

Accepted Answer

Ototoxicity

Answer

Gentamicin is an aminoglycoside antibiotic known for its potential to cause nephrotoxicity and ototoxicity. Trough concentrations are monitored to ensure the drug is being adequately cleared from the body between doses. Elevated trough levels indicate accumulation and are strongly associated with an increased risk of toxicity, particularly to the ears (ototoxicity) and kidneys (nephrotoxicity).

Question 5

According to the National Competency Standards Framework for Pharmacists in Australia, monitoring medication outcomes is a core component of which domain?

Accepted Answer

Review and Manage Medication Management Plans

Answer

The National Competency Standards Framework for Pharmacists in Australia (2016) outlines the required skills and knowledge for pharmacists. The domain that encompasses formulating, implementing, and monitoring the outcomes of medication management plans is 'Domain 3: Review and Manage Medication Management Plans'. This includes assessing the patient's response to therapy and recommending adjustments as needed.

CAOP - Competency Assessment of Overseas Pharmacist Practice Test

CAOP - Competency Assessment of Overseas Pharmacist Practice Test

CAOP - Competency Assessment of Overseas Pharmacist Monitoring Medication Outcomes Questions and Answers